文献速递神经肿瘤

海绵窦脑膜瘤治疗后视觉功能结局的预测因素

Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
PubMed 文献 · J Neurosurg · 2020-05-15

这项回顾性研究纳入2000至2018年间44例海绵窦脑膜瘤患者,评估手术、立体定向放射外科或放疗后视觉功能结局。多因素分析显示,治疗前同侧视力缺陷、视盘苍白、眼压升高及眼外肌受限可预测治疗后相应视觉功能不良。

要点

  • 治疗前同侧视力差和视盘苍白与治疗后同侧视力缺陷相关。
  • 治疗前同侧眼压高预示治疗后同侧眼压升高。
  • 治疗前眼外肌受限预示治疗后眼外肌受限。

核心结论

  • 治疗前视觉功能评估可预测海绵窦脑膜瘤患者治疗后的视觉结局,并识别视力丧失高风险患者。

研究设计与样本

  • 回顾性队列研究,纳入2000至2018年间在学术三级医院就诊的连续海绵窦脑膜瘤患者44例(73%女性,中位年龄55岁),中位临床随访14个月。

主要发现

  • 单独次全切除后同侧视力缺陷改善、稳定、恶化分别为0%、33.4%、66.6%。
  • 次全切除加放疗后同侧视力缺陷改善、稳定、恶化分别为52.6%、31.6%、15.8%。
  • 单独放疗(立体定向放射外科或立体定向放疗)后同侧视力缺陷改善、稳定、恶化分别为56.3%、43.7%、0%。

关键数值与推荐

  • 调整年龄、肿瘤体积和治疗方式后,初始同侧视力缺陷(OR 10.1,95%CI 1.05-97.2,p=0.04)和初始同侧视盘苍白(OR 21.1,95%CI 1.6-270.5,p=0.02)与治疗后同侧视力缺陷相关。
  • 初始视盘苍白(OR 15.7,95%CI 1.3-199.0,p=0.03)、初始视力缺陷(OR 21.7,95%CI 1.2-398.6,p=0.03)和同侧眼压较高(OR 55.3,95%CI 1.7-173.9,p=0.02)与治疗后同侧视盘苍白相关。
  • 初始同侧眼压较高(OR 35.9,95%CI 3.3-400.5,p=0.004)预示治疗后同侧眼压升高。
  • 初始眼外肌受限预示治疗后眼外肌受限(OR 20.6,95%CI 18.7-77.0,p=0.02)。

临床怎么用

  • 治疗前应详细评估视力、视盘、眼压和眼外肌功能,以识别治疗后视力丧失高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cavernous sinus meningioma (CSM) can affect visual function and require expeditious treatment to prevent permanent visual loss. Authors of this retrospective study sought to determine the factors associated with visual functional outcomes in CSM patients treated with surgery, stereotactic radiosurgery (SRS), or stereotactic radiation therapy (SRT), alone or in combination. METHODS: Consecutive patients with CSM who had presented at an academic tertiary care hospital from 2000 to 2018 were identified through retrospective chart review. Visual function-visual eye deficit (VED), optic disc (OD) appearance, intraocular pressure (IOP), and extraocular movement (EOM)-was assessed before and after treatment for CSM. VED with visual acuity (VA) ≤ 20/200 and visual field defect ≥ -11 dB, pale OD appearance in the ipsilateral or contralateral eye, increased ipsilateral IOP, and/or EOM restriction were defined as a poor visual functional outcome. Multivariable logistic regression was used to evaluate the associations between pretreatment visual functional assessment and posttreatment visual outcomes. RESULTS: The study cohort included 44 patients (73% female; median age 55 years), with a median clinical follow-up of 14 months. Ipsilateral VED improved, remained stable, or worsened, respectively, in 0%, 33.4%, and 66.6% of the patients after subtotal resection (STR) alone; in 52.6%, 31.6%, and 15.8% after STR plus radiation treatment; in 28.5%, 43.0%, and 28.5% after gross-total resection (GTR) alone; and in 56.3%, 43.7%, and 0% after radiation treatment (SRS or SRT) alone. Contralateral VED remained intact in all the patients after STR alone and those with radiation treatment (SRS or SRT) alone; however, it improved, remained stable, or worsened in 10.5%, 84.2%, and 5.3% after STR plus radiation treatment and in 43.0%, 28.5%, and 28.5% after GTR alone. EOM remained intact, fully recovered, remained stable, and worsened, respectively, in 0%, 50%, 50%, and 0% of the patients after STR alone; in 36.8%, 47.4%, 15.8%, and 0% of the patients after STR with radiation treatment; in 57.1%, 0%, 28.6%, and 14.3% of the patients after GTR alone; and in 56.2%, 37.5%, 6.3%, and 0% of the patients after radiation treatment (SRS or SRT) alone. In multivariable analyses adjusted for age, tumor volume, and treatment modality, initial ipsilateral poor VED (OR 10.1, 95% CI 1.05-97.2, p = 0.04) and initial ipsilateral pale OD appearance (OR 21.1, 95% CI 1.6-270.5, p = 0.02) were associated with poor ipsilateral VED posttreatment. Similarly, an initial pale OD appearance (OR 15.7, 95% CI 1.3-199.0, p = 0.03), initial poor VED (OR 21.7, 95% CI 1.2-398.6, p = 0.03), and a higher IOP in the ipsilateral eye (OR 55.3, 95% CI 1.7-173.9, p = 0.02) were associated with an ipsilateral pale OD appearance posttreatment. Furthermore, a higher initial ipsilateral IOP (OR 35.9, 95% CI 3.3-400.5, p = 0.004) was indicative of a higher IOP in the ipsilateral eye posttreatment. Finally, initial restricted EOM was indicative of restricted EOM posttreatment (OR 20.6, 95% CI 18.7-77.0, p = 0.02). CONCLUSIONS: Pretreatment visual functional assessment predicts visual outcomes in patients with CSM and can be used to identify patients at greater risk for vision loss.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Fatima N, Ding VY, Han SS, et al. Predictors of visual functional outcome following treatment for cavernous sinus meningioma. J Neurosurg. 2020. PMID: 32413851. doi:10.3171/2020.2.JNS193009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。